CORRECTION FROM SOURCE: Zomedica Pushes TRUFORMA(TM) Closer To Commercialization, Targeting $2.7 Billion Companion Animal Diagnostics Market
A copy of the entire release follows.Miami Beach, Florida--(Newsfile Corp. - October 3, 2019) - Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSXV: ZOM) is...
2019-10-03 11:27 AM EDT
Zomedica Pushes TRUFORMA (TM) Closer To Commercialization, Targeting $2.7 Billion Companion Animal Diagnostics Market
Miami Beach, Florida--(Newsfile Corp. - October 1, 2019) - Zomedica, Inc. (NYSE American: ZOM) (TSXV: ZOM) is getting closer to commercializing its first potentially industry-changing product, TRUFORMA™, a point of care diagnostic platform with initial assays used to diagnose thyroid and adrenal disorders in dogs and cats. The device, which is on pace to launch by the end of first quarter of 2020, is expecting to earn a large share of the estimated $2.7 billion companion pet diagnostic...
2019-10-01 9:17 AM EDT
IIROC Trade Resumption - Zomedica Pharmaceuticals Corp.
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2016) - Trading resumes in: Company: Zomedica Pharmaceuticals Corp.
2016-04-29 4:15 PM EDT
IIROC Trade Halt - Wise Oakwood Ventures Inc.
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2015) - The following issues have been halted by IIROC: Company:
2015-10-30 8:02 AM EDT
IIROC Trade Resumption - Wise Oakwood Ventures Inc.
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2015) - Trading resumes in: Company: Wise Oakwood Ventures Inc.
2015-02-09 4:19 PM EST
IIROC Trade Halt - Wise Oakwood Ventures Inc.
Vancouver, British Columbia--(Newsfile Corp. - September 29, 2014) - The following issues have been halted by IIROC: Company:
2014-09-29 7:57 AM EDT